lung cancer
Conditions
Interventions
control group:Routing chemo-radio therapy
Sponsors
Weifang Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: The patients signed informed consent, and have good compliance; (2)The patients who be considered as NSCLC due to clinical symptoms or CT, MRI and other non-invasive examination can be used as a pre-filter object; (3)Before pre-screening there is not any surgery, radiotherapy, chemotherapy, immunotherapy, and traditional Chinese medicine as an antitumor therap; (4) before the pre-screening, according to the RECIST criteria (Evaluation Criteria in Solid tumors) definition, there must be measurable disease; (5) after the pre-screening,stage I, II, III, IV non-small cell lung cancer patients who confirmed histologically or cytologically; (6) aged 18-75 years old;
Exclusion criteria
Exclusion criteria: (1) can not use language to express their demands or independent communicators; (2) women during pregnancy or breast-feeding, psychiatric patients, criminals, soldiers and other vulnerable groups; (3) According to the investigator's judgment, there is serious harm to patient safety, or concomitant diseases which affected patients to complete the study and may cause bias of the findings, such as combining interstitial lung disease, tuberculosis, blood diseases, heart disease, diabetes, hypertension and other chronic diseases or other malignancies; (4) treatment program will include surgery removal, biological immune therapy and EGFR inhibitors (EGFR TKI) persons; (5) researchers participating in other clinical.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Measurable disease according to Response Evaluation;The quality of life according to FACT-L table;Toxic effects according to the RTOG radiation reaction;Pregression Free Survival time;Overall Survival;Median Survival Time; | — |
Countries
China
Contacts
Public ContactChanggang Sun
Weifang Chinese Medicine Hospital
Outcome results
None listed